These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13599647)

  • 1. [Serum protein examinations in scleroderma and Sjoegren syndrome].
    OBLATT E; FEHER L; CSIKI T
    Magy Belorv Arch (1955); 1958; 11(2-3):66-9. PubMed ID: 13599647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum protein studies in scleroderma and Sjögren syndrome].
    OBLATT E; FEHER L; CSIKY T
    Klin Wochenschr; 1958 Aug; 36(16):769-72. PubMed ID: 13576763
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Generalized scleroderma associated with the Gougerot-Sjoegren syndrome and vitiligo].
    PALACIO J; PERRETTA A; GUIDO JJ; VILLA JJ
    Prensa Med Argent; 1959 May; 46():1315-20. PubMed ID: 14429873
    [No Abstract]   [Full Text] [Related]  

  • 5. Sjogren's syndrome.
    MACLEAN K; ROBINSON HS
    Can Med Assoc J; 1954 Dec; 71(6):597-9. PubMed ID: 13209455
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 7. Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systemic sclerosis and rheumatoid arthritis.
    Horrobin DF
    Scand J Rheumatol Suppl; 1986; 61():242-5. PubMed ID: 3296151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unusual combination of diseases: Sjögren's syndrome, scleroderma & arthrosis].
    NATALE P; CERVINI C
    Prog Med (Napoli); 1957 Aug; 13(16):502-9. PubMed ID: 13485203
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of Sjögren's disease with scleroderma.
    HARRINGTON AB; DEWAR HA
    Br Med J; 1951 Jun; 1(4718):1302-3. PubMed ID: 14839253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
    Wysocka K; Kiczak J
    Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
    [No Abstract]   [Full Text] [Related]  

  • 11. Sjogren's syndrome in association with scleroderma.
    SHEARN MA
    Ann Intern Med; 1960 Jun; 52():1352-62. PubMed ID: 14445694
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of scleroderma with facial diplegia and Sjögren syndrome].
    PIAZZESI W
    Riv Patol Nerv Ment; 1956; 77(2):584-92. PubMed ID: 13390690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sjögren's syndrome: serum proteins and autoimmune phenomena].
    Meiers HG; Voigtmann G; Haensch R; Hornstein OP
    Hautarzt; 1974 Mar; 25(3):118-23. PubMed ID: 4211240
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated sicca syndrome and scleroderma-specific autoantibodies: Sjögren's syndrome or early Systemic Sclerosis localized in salivary glands?
    Marketos N; Mavragani CP
    Semin Arthritis Rheum; 2023 Feb; 58():152156. PubMed ID: 36580853
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum level of IL-6 in patients with primary and secondary Sjögren's syndrome.
    Slezák R; Krejsek J; Kopecký O; Jelenová H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(2):59-60. PubMed ID: 8584859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
    Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
    J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
    Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dacryosialoadenopathia atrophicans and sclerodermia.
    ERCOLI G; LEPRI G
    Ophthalmologica; 1952 Sep; 124(3):129-41. PubMed ID: 13013710
    [No Abstract]   [Full Text] [Related]  

  • 19. Sjögren's syndrome and multiple sclerosis.
    Poser CM
    Ann Neurol; 1991 Apr; 29(4):455-6. PubMed ID: 1929217
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary Sjogren's syndrome and scleroderma presenting as renal tubular acidosis.
    Baburaj P; Khanna L
    J Assoc Physicians India; 2007 Jan; 55():78-9. PubMed ID: 17444349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.